Antibiotics, Antitubercular
"Antibiotics, Antitubercular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic.
| Descriptor ID |
D000904
|
| MeSH Number(s) |
D27.505.954.122.085.255.135
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibiotics, Antitubercular".
Below are MeSH descriptors whose meaning is more specific than "Antibiotics, Antitubercular".
This graph shows the total number of publications written about "Antibiotics, Antitubercular" by people in this website by year, and whether "Antibiotics, Antitubercular" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2017 | 6 | 11 | 17 |
| 2018 | 10 | 7 | 17 |
| 2019 | 4 | 0 | 4 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibiotics, Antitubercular" by people in Profiles.
-
Rifampicin-Induced Pneumonitis Mimicking Severe COVID-19 Pneumonia Infection. Am J Case Rep. 2020 Aug 25; 21:e927586.
-
Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study. Clin Infect Dis. 2019 09 27; 69(8):1278-1287.
-
Severe disseminated tuberculosis in HIV-negative refugees. Lancet Infect Dis. 2019 10; 19(10):e352-e359.
-
Pharmacokinetics of dolutegravir 100 mg once daily with rifampicin. Int J Antimicrob Agents. 2019 Aug; 54(2):202-206.
-
Use of Rifabutin as an Alternative Agent for Human Brucellosis: A Case Report. Chemotherapy. 2018; 63(6):321-323.
-
Clinical characteristics and early outcomes of patients newly diagnosed with pulmonary Mycobacterium avium complex disease. Respir Investig. 2019 Jan; 57(1):54-59.
-
How well does the process of screening and diagnosis work for HIV-infected persons identified with presumptive tuberculosis who are attending HIV care and treatment clinics in Harare city, Zimbabwe? Trans R Soc Trop Med Hyg. 2018 Oct 01; 112(10):450-457.
-
Comparative evaluation of Xpert MTB/RIF assay with multiplex polymerase chain reaction for the diagnosis of tuberculous meningitis. Tuberculosis (Edinb). 2018 12; 113:38-42.
-
Prevalence of rifampicin resistant tuberculosis and associated factors among presumptive tuberculosis patients in a secondary referral hospital in Lagos Nigeria. Afr Health Sci. 2018 Sep; 18(3):472-478.
-
Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis. J Antimicrob Chemother. 2018 09 01; 73(9):2305-2313.